Jump to navigation
Enter the article’s url One of our curators will take care of it as soon as possible!
Subscribe to our weekly newsletter.
European Patent Office revokes patent on gene-editing technology.
As a culture and a profession, medicine continues to systematically disadvantage women physicians at every stage of their careers.
Six drug firms are paying to sequence the genes of every volunteer in the UK Biobank.
The goal is to customize treatments for cancer and other diseases to a patient's own biology. But something as simple as failing to take care of tissue samples en route to the lab can derail that.
Technology could be used to wipe out malaria carrying mosquitos or other pests but UN experts say fears over possible military uses and unintended consequences strengthen case for a ban.
The National Academy of Sciences called on the federal government to make drastic policy changes to bring down the cost of prescription medicines.
Peer review decisions award >95% of academic medical research funding, so it is crucial to understand how well they work and if they could be improved.
When a clinical trial falters, doctors find themselves sifting through the rubble.
Adequate sample size is key to reproducible research findings: low statistical power can increase the probability that a statistically significant result is a false positive.
In this piece, I will explain how the explanation of the emergence of life could also explain the mechanism of Deep Learning.
A US Research Integrity Advisory Board is long overdue. Such a leadership body would mitigate bad practices and strengthen good research.
London’s loss, as a result of Brexit vote, is lamented by U.K. researchers
Missing trial results undermine pandemic preparedness
The medicine, an antipsychotic drug, has a sensor that will show doctors whether and when patients are taking it. Other medicines will follow, experts say.
Huge genetic databases are changing how scientists study disease.
NIH Data Commons Pilot Phase to seek best practices for developing and managing a data commons.
Thomas Insel's biggest lesson from his shift from NIMH director to Silicon Valley entrepreneur: academic and technology company researchers should partner up.
More than 400 Pennsylvanians have already learned of disease mutations.
ADC Therapeutics, a Swiss start-up that specialises in cutting-edge cancer drugs, has raised almost CHF200 million ($200 million) in private funds.
Why Greek and Latin medical terminology is better off dead.